These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology. Billingsley KJ; Manca M; Gianfrancesco O; Collier DA; Sharp H; Bubb VJ; Quinn JP Schizophr Res; 2018 Sep; 199():168-175. PubMed ID: 29501388 [TBL] [Abstract][Full Text] [Related]
9. Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C. Erk S; Meyer-Lindenberg A; Schmierer P; Mohnke S; Grimm O; Garbusow M; Haddad L; Poehland L; Mühleisen TW; Witt SH; Tost H; Kirsch P; Romanczuk-Seiferth N; Schott BH; Cichon S; Nöthen MM; Rietschel M; Heinz A; Walter H Biol Psychiatry; 2014 Sep; 76(6):466-75. PubMed ID: 24411473 [TBL] [Abstract][Full Text] [Related]
10. Enhanced long-term potentiation and impaired learning in mice lacking alternative exon 33 of Ca Navakkode S; Zhai J; Wong YP; Li G; Soong TW Transl Psychiatry; 2022 Jan; 12(1):1. PubMed ID: 35013113 [TBL] [Abstract][Full Text] [Related]
11. Association of CACNA1C polymorphisms with serum BDNF levels in bipolar disorder. Smedler E; Pålsson E; Hashimoto K; Landén M Br J Psychiatry; 2021 Feb; 218(2):77-79. PubMed ID: 31317860 [TBL] [Abstract][Full Text] [Related]
12. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia. Yang YJ; Li YK; Wang W; Wan JG; Yu B; Wang MZ; Hu B Pharmacol Biochem Behav; 2014 Jul; 122():30-6. PubMed ID: 24662915 [TBL] [Abstract][Full Text] [Related]
13. The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. Berger SM; Bartsch D Cell Tissue Res; 2014 Aug; 357(2):463-76. PubMed ID: 24996399 [TBL] [Abstract][Full Text] [Related]
14. The effect of psychosis associated CACNA1C, and its epistasis with ZNF804A, on brain function. Tecelão D; Mendes A; Martins D; Fu C; Chaddock CA; Picchioni MM; McDonald C; Kalidindi S; Murray R; Prata DP Genes Brain Behav; 2019 Apr; 18(4):e12510. PubMed ID: 30079586 [TBL] [Abstract][Full Text] [Related]
15. Sex-specific effects of Cacna1c haploinsufficiency on object recognition, spatial memory, and reversal learning capabilities in rats. Braun MD; Kisko TM; Vecchia DD; Andreatini R; Schwarting RKW; Wöhr M Neurobiol Learn Mem; 2018 Nov; 155():543-555. PubMed ID: 29800644 [TBL] [Abstract][Full Text] [Related]
16. Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. Gassó P; Sánchez-Gistau V; Mas S; Sugranyes G; Rodríguez N; Boloc D; de la Serna E; Romero S; Moreno D; Moreno C; Díaz-Caneja CM; Lafuente A; Castro-Fornieles J Psychiatry Res; 2016 Nov; 245():427-435. PubMed ID: 27620326 [TBL] [Abstract][Full Text] [Related]
17. Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects. Erk S; Meyer-Lindenberg A; Linden DEJ; Lancaster T; Mohnke S; Grimm O; Degenhardt F; Holmans P; Pocklington A; Schmierer P; Haddad L; Mühleisen TW; Mattheisen M; Witt SH; Romanczuk-Seiferth N; Tost H; Schott BH; Cichon S; Nöthen MM; Rietschel M; Heinz A; Walter H Neuroimage; 2014 Jul; 94():147-154. PubMed ID: 24642287 [TBL] [Abstract][Full Text] [Related]
18. What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review. Gurung R; Prata DP Psychol Med; 2015; 45(12):2461-80. PubMed ID: 25858580 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the Expression of the Psychiatric Risk Gene Sykes L; Clifton NE; Hall J; Thomas KL Mol Neuropsychiatry; 2018 Dec; 4(3):149-157. PubMed ID: 30643788 [No Abstract] [Full Text] [Related]
20. Variation in CACNA1C is Associated with Amygdala Structure and Function in Adolescents. Sumner JA; Sheridan MA; Drury SS; Esteves KC; Walsh K; Koenen KC; McLaughlin KA J Child Adolesc Psychopharmacol; 2015 Nov; 25(9):701-10. PubMed ID: 26401721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]